相关实验视频

Updated: Jul 28, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.6K

优化一系列新型,强效和选择性的宏循环SYK抑制剂

Neil P Grimster1, Lakshmaiah Gingipalli1, Amber Balazs1

  • 1Oncology R & D, AstraZeneca, Waltham, USA.

Bioorganic & medicinal chemistry letters
|June 3, 2023
PubMed
概括

研究人员设计了新的宏环抑制剂,针对脏氨酸激酶 (SYK),这是一个关键的信号蛋白. 这些强大的SYK抑制剂具有很高的选择性和稳定性,为各种疾病提供新的治疗潜力.

关键词:
DLBCL DLBCL 是一个字.基因酶激酶的使用方法宏观循环是一个宏观循环.这就是SYK.

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K